Cleararc Capital Inc. increased its position in shares of Clorox Company (The) (NYSE:CLX) by 0.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,146 shares of the company’s stock after buying an additional 23 shares during the period. Cleararc Capital Inc.’s holdings in Clorox Company (The) were worth $424,000 as of its most recent filing with the SEC.

A number of other large investors also recently made changes to their positions in the stock. Manning & Napier Advisors LLC raised its stake in shares of Clorox Company (The) by 7.1% in the first quarter. Manning & Napier Advisors LLC now owns 22,261 shares of the company’s stock worth $3,001,000 after buying an additional 1,478 shares during the last quarter. Chevy Chase Trust Holdings Inc. raised its stake in Clorox Company (The) by 1.6% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 129,249 shares of the company’s stock valued at $17,427,000 after buying an additional 1,990 shares in the last quarter. Park National Corp OH raised its stake in Clorox Company (The) by 6.5% in the first quarter. Park National Corp OH now owns 5,440 shares of the company’s stock valued at $733,000 after buying an additional 331 shares in the last quarter. Macquarie Group Ltd. raised its stake in Clorox Company (The) by 6.5% in the fourth quarter. Macquarie Group Ltd. now owns 6,600 shares of the company’s stock valued at $792,000 after buying an additional 400 shares in the last quarter. Finally, Highbridge Capital Management LLC acquired a new stake in Clorox Company (The) during the fourth quarter valued at approximately $7,801,000. Institutional investors own 70.56% of the company’s stock.

Clorox Company (NYSE:CLX) traded up 2.09% during mid-day trading on Thursday, hitting $134.73. 1,239,073 shares of the stock traded hands. The stock has a market cap of $17.35 billion, a PE ratio of 26.57 and a beta of 0.40. Clorox Company has a 12-month low of $111.24 and a 12-month high of $141.76. The company has a 50 day moving average of $134.79 and a 200-day moving average of $133.07.

Clorox Company (The) (NYSE:CLX) last released its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 215.99% and a net margin of 11.22%. The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.65 billion. During the same quarter last year, the firm posted $1.30 EPS. The company’s revenue was up 2.9% on a year-over-year basis. Equities research analysts forecast that Clorox Company will post $5.31 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 4th. Stockholders of record on Wednesday, July 19th will be issued a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a dividend yield of 2.49%. The ex-dividend date is Monday, July 17th. This is a positive change from Clorox Company (The)’s previous quarterly dividend of $0.80. Clorox Company (The)’s dividend payout ratio (DPR) is presently 66.27%.

WARNING: This article was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark laws. The correct version of this article can be viewed at https://www.thecerbatgem.com/2017/08/03/clorox-company-the-nyseclx-stake-boosted-by-cleararc-capital-inc-updated-updated-updated.html.

Several equities research analysts have recently commented on CLX shares. Zacks Investment Research upgraded shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $151.00 price target for the company in a report on Wednesday, April 5th. Citigroup Inc. boosted their price target on shares of Clorox Company (The) from $75.00 to $76.00 and gave the company a “neutral” rating in a report on Friday, April 7th. Jefferies Group LLC started coverage on shares of Clorox Company (The) in a report on Tuesday, April 18th. They issued a “hold” rating and a $138.00 price target for the company. Vetr lowered shares of Clorox Company (The) from a “buy” rating to a “hold” rating and set a $139.67 price objective for the company. in a research note on Tuesday, April 18th. Finally, Royal Bank Of Canada set a $115.00 price objective on shares of Clorox Company (The) and gave the stock a “hold” rating in a research note on Monday, April 24th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and three have assigned a buy rating to the stock. Clorox Company (The) currently has an average rating of “Hold” and a consensus price target of $128.48.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.